Removal of bronchoalveolar cells augments the late eosinophilic response to segmental allergen challenge
Related Experiment Video
Updated: Jul 4, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 14, 2010
1Division of Allergic Diseases/Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA. lhunt330@Bellsouth.net
Background:
In patients with quiescent asthma, macrophages are the most prevalent cells recovered by bronchoalveolar lavage (BAL). Through activation via their FcepsilonRII receptors or by acting as antigen-presenting cells, macrophages could, in theory, promote the late airway response to allergen.
Objective:
In order to investigate the importance of macrophages and other airway luminal cells in inducing the late airway response, a novel washout experiment was designed.
Methods:
Five patients with ragweed-allergic asthma underwent bronchoscopy and segmental bronchial challenge with either normal saline or short ragweed extract in two segments of one lung. In a third segment of the opposite lung, 12 successive BALs (25 mL each) were performed, followed by challenge with an identical dose of short ragweed (washed-challenged segment). After 24 h, all three challenged segments underwent BAL.
Results:
Initially, in the washed-challenged segment, over 80% (mean 80.4%, range 68-88%) of the recoverable airway dwelling cells were removed. Unexpectedly, 24 h later these same washed-challenged segments contained more eosinophils in the BAL than the challenged segments from the opposite lung (P = 0.033).
Conclusions:
Removing the majority of airway luminal cells followed by allergen bronchoprovocation increased the number of eosinophils recovered 24 h after challenge. Our results suggest that in quiescent allergic asthma, the airway luminal cells are protective and attenuate the late eosinophilic response to allergen challenge.
Insights
In allergic asthma, removing airway cells surprisingly increased eosinophils after allergen challenge. This suggests airway luminal cells normally protect against late allergic responses.
Area of Science:
- Pulmonary Medicine
- Immunology
- Allergy Research
Background:
- Macrophages are the predominant cells in quiescent asthma patients' bronchoalveolar lavage (BAL).
- Airway macrophages may promote late allergic airway responses via FcepsilonRII receptors or antigen presentation.
Purpose of the Study:
- To investigate the role of macrophages and airway luminal cells in the late asthmatic response.
- To design a novel washout experiment to assess the impact of cell removal on airway inflammation.
Main Methods:
- Five patients with ragweed-allergic asthma underwent bronchoscopy.
- Segmental bronchial challenge with saline or ragweed extract was performed.
- A novel washout technique removed over 80% of airway cells before allergen challenge in one segment.
Main Results:
- The washed-challenged segment showed a significant increase in eosinophils 24 hours post-challenge compared to controls (P=0.033).
- Unexpectedly, removing the majority of airway luminal cells led to a heightened eosinophilic response.
Conclusions:
- Airway luminal cells appear to have a protective role in quiescent allergic asthma.
- These cells attenuate the late eosinophilic inflammatory response to allergen challenge.
Related Concept Videos
Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

